Treos Bio Inc is a clinical stage company based in Bethesda, MD, that is revolutionizing cancer immunotherapy development through its disruptive computational technology. By addressing the challenges of patient and tumor heterogeneity, Treos Bio utilizes proprietary therapeutic peptides to stimulate clinically effective cancer-specific immune responses in patients predicted to respond by their diagnostic tests.
With a focus on off-the-shelf personalized peptide cancer immunotherapies, off-the-shelf peptide cancer immunotherapies, and PolyPEPI preventive vaccines, Treos Bio is dedicated to providing innovative solutions in the field of cancer treatment.
Generated from the website
